Hansa Biopharma’s Biologics License Application (BLA) for imlifidase accepted by the FDA Hansa Biopharma announced that its Biologics License Application (BLA) for imlifidase has been accepted by the U.S. Food and Drug Administration (FDA). The BLA submission for imlifidase is supported by the previously communicated highly statistically significant outcome of the pivotal U.S. Phase 3 […]
Let’s talk antibiotics. Specifically: Is our policy about how we might use new antibiotics, wrong? A little on background first. Resistance to existing antibiotics is growing and the pipeline of new ones is thin. If we don’t get our act together – so the warnings go – we’ll sleepwalk into a post-antibiotic apocalypse, where surgery is a nightmare and a scratch could be deadly. Current thinking is that […]
European Life Sciences Coalition launched to strengthen Europe’s life sciences investment ecosystem The European Life Sciences Coalition (ELSC) launched this week to strengthen Europe’s life sciences and biotechnology VC ecosystem by mobilising greater levels of private and public investment across the sector. Created in association with Invest Europe, the coalition brings together leading European life […]
To mark this year’s International Day of Women and Girls in Science, Optimum is celebrating the remarkable women across our network by asking them: ‘If you could collaborate with any scientist (past or present) who would it be, and why?’ Their answers were as inspiring as they were diverse, from trailblazing pioneers to modern innovators, […]
Biocomposites gains MDR certification for STIMULAN® Rapid Cure and STIMULAN® Kit Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, has secured European Union Medical Device Regulation (MDR) certification for its STIMULAN® products. The approval confirms that STIMULAN® can be mixed with […]
